WEB 2086 (Synonyms: WEB 2086) |
Catalog No.GC14161 |
WEB 2086 (WEB 2086), un puissant antagoniste du facteur d'activation plaquettaire (PAF), inhibe la liaison du PAF aux récepteurs humains du PAF avec un Ki de 9,9 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 105219-56-5
Sample solution is provided at 25 µL, 10mM.
Apafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM[1].
References:
[1]. Kato M, et al. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. J Pharmacol Sci. 2004 Aug;95(4):435-42.
Average Rating: 5
(Based on Reviews and 25 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *